Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: Feasibility of the method and initial results

European Journal of Radiology

Volumn 64, Issue 2, 2007, Pages 258-265

  Bisdas, S ^a   Baghi, M ^a   Wagenblast, J ^a   Knecht, R ^a   Thng, C H ^b   Koh, T S ^c   Vogl, T J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Benign and malignant parotid neoplasms; Blood flow; Blood volume; Mean transit time; Perfusion CT; Permeability surface area product

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CORRELATION METHODS; DATA REDUCTION; MAGNETIC PERMEABILITY; SURFACE ANALYSIS; TRANSIT TIME DEVICES;

BENIGN AND MALIGNANT PAROTID NEOPLASMS; BLOOD FLOW; BLOOD VOLUME; MEAN TRANSIT TIME; PERFUSION CT; PERMEABILITY SURFACE AREA PRODUCT;

TUMORS;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLOOD FLOW; BLOOD VOLUME; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE PROCESSING; MALE; MALIGNANT NEOPLASTIC DISEASE; PAROTID GLAND TUMOR; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TISSUE PERFUSION; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADENOLYMPHOMA; ADENOMA, PLEOMORPHIC; AGED; BLOOD VOLUME; CAPILLARY PERMEABILITY; CARCINOMA, ADENOID CYSTIC; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IOPAMIDOL; MALE; MIDDLE AGED; PAROTID GLAND; PAROTID NEOPLASMS; RADIOGRAPHIC IMAGE ENHANCEMENT; REGIONAL BLOOD FLOW; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35348848970     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.02.032     Document Type: Article

References (20)

1. Howlett D.C., Kess K.W., Hughes D.V., et al. The role of imaging in the evaluation of parotid disease. Clin Radiol 57 (2002) 692-701
2. Bisdas S., Donnerstag F., Ahl B., et al. Comparison of perfusion computed tomography with diffusion-weighted magnetic resonance imaging in hyperacute ischemic stroke. J Comput Assist Tomogr 28 (2004) 747-755
3. Roberts H.C., Roberts T.P.L., Lee T.Y., et al. Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow and microvascular permeability: report of two cases. AJNR Am J Neuroradiol 23 (2002) 828-832
4. Hermans R., Lambin P., Van der Goten A., et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiol Oncol 53 (1999) 105-111
5. Rumboldt Z., Al-Okaili R., and Deveikis J.P. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol 26 (2005) 1178-1185
6. Lee T.Y. Functinal CT: physiological models. Trends Biotechnol 20 Suppl. (2002) S3-S10
7. Nabavi D.G., Cenic A., Craen R.A., et al. CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 213 (1999) 141-149
8. Zbären P., Schär C., Hotz M.A., and Loosli H. Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope 111 (2001) 1989-1992
9. Hee C.G., and Perry C.F. Fine-needle aspiration cytology of parotid tumors. Is it useful?. Aust NZ J Surg 71 (2001) 345-348
10. Howlett D.V. Diagnosing a parotid lump: fine needle aspiration cytology or core biopsy?. Br J Radiol 79 (2006) 295-297
11. Tsushima Y., Matsumoto M., and Endo K. Parotid and parapharyngeal tumors: tissue characterization with dynamic magnetic resonance imaging. Br J Radiol 67 (1994) 342-345
12. Yabuuchi H., Fukuya T., TajimaT, Hachitanda Y., Tomita K., and Koga M. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology 226 (2003) 345-354
13. Hisatomi M., Asaumi J.U., Konouchi H., Yanagi Y., Matzuzaki H., and Kishi K. Assessment of dynamic MRI of Warthin' tumors arising as multiple lesions in the parotid glands. Oral Oncology 38 (2002) 369-372
14. Takashima S., Noguchi Y., Okumura T., et al. Dynamic MR imaging in the head and neck. Radiology 189 (1993) 813-821
15. Wang P.Z., Yu Q., Shi H.M., et al. Diagnostic value of CT perfusion for parotid gland tumors. Shanghai Kou Qiang Yi Xue 14 (2005) 573-577
16. Ikeda M., Motoori K., Hanazawa T., et al. Whartin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation. AJNR Am J Neuroradiol 25 (2004) 1256-1262
17. Gandhi D., Hoeffner E.G., Carlos R.C., Case I., and Mukherji S.K. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr 27 (2003) 687-693
18. Bisdas S., Baghi M., Smolarz A., et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 42 (2007) 172-179
19. Goh V., Halligan S., Hugill J.A., et al. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced, multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr 29 (2005) 59-63
20. Lev M.H., Khanduja K., Morris P.P., and Curtin H.D. Parotid pleomorphic adenomas: delayed CT enhancement. AJNR Am J Neuroradiol 19 (1998) 1835-1839